Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Fengxiao Xie

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5066968597. Sources: OpenAlex.

Their work

Papers
5
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 5

  1. Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer [Cancer Lett. 502 (2021) 9-24]. Co-author DOI 10.1016/j.canlet.2024.216697↗
  2. An Inflammatory Response-Related Gene Signature Reveals Distinct Survival Outcome and Tumor Microenvironment Characterization in Pancreatic Cancer. Co-author DOI 10.3389/fmolb.2022.876607↗
  3. Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2020.12.018↗
  4. The role of irreversible electroporation in promoting M1 macrophage polarization via regulating the HMGB1-RAGE-MAPK axis in pancreatic cancer. Co-author DOI 10.1080/2162402x.2021.1897295↗
  5. SYPL1 Inhibits Apoptosis in Pancreatic Ductal Adenocarcinoma via Suppression of ROS-Induced ERK Activation. Co-author DOI 10.3389/fonc.2020.01482↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shengping Li · 5 shared papers, 2020–2024 · strength 0.76
  2. Chaobin He · 5 shared papers, 2020–2024 · strength 0.76
  3. Xin Huang · 4 shared papers, 2020–2024 · strength 0.59
  4. Shuxin Sun · 4 shared papers, 2020–2024 · strength 0.56
  5. Guangmei Yan · 2 shared papers, 2021–2024 · strength 0.29
  6. Jing Cai · 2 shared papers, 2021–2024 · strength 0.29
  7. Jun Wang · 1 shared paper, 2024 · strength 0.18
  8. Yunda Song · 1 shared paper, 2020 · strength 0.10
  9. Yize Mao · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.